NEW

Johnson & Johnson to Acquire Shockwave Medical

Johnson & Johnson and Shockwave Medical, Inc. today announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Shockwave for $335 per share in cash, corresponding to an enterprise value of...

Medline Expands Catheter Portfolio

Medline and Consure Medical have announced a new agreement for Medline to exclusively distribute the QiVi MEC male external urine management device to help guard against catheter-associated urinary tract infections (CAUTI) and incontinence-associated dermatitis (IAD)....

FDA Clears Single-use Flexible Ureteroscope

Olympus, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced U.S. FDA 510(k) clearance of its first single-use ureteroscope system, RenaFlex™, with full market availability to be announced at a later...

Brainlab, Fujifilm Offer Advanced Neurosurgery Capabilities

FUJIFILM Healthcare Americas Corporation and Brainlab recently announced that Brainlab will be the exclusive U.S. distributor of ARIETTA Precision Ultrasound for neurosurgery applications to be utilized with Brainlab’s surgical navigation systems. ARIETTA Precision,...

STERILUCENT, INC. ANNOUNCES CLEARANCE TO MARKET NEW LOW-TEMPERATURE STERILIZATION SYSTEM

New sterilizer’s unique features address longstanding process challenges

Tuesday, October 1, 2019: Sterilucent, Inc. (Minneapolis, MN), announces that the company has received regulatory clearance to market the Sterilucent™ HC 80TT Vaporized Hydrogen Peroxide Sterilizer with Cycle Guardian™ technology in the United States. Cycle Guardian technology includes:

  • Advanced and continuous critical parameter monitoring capability, which enables advanced dynamic sterilant delivery, confirms that the minimum required concentration of the sterilant is maintained, and optimizes the sterilant for each specific load in the chamber
  • Enhanced and customized drying capability that results in fewer aborted cycles
  • Cycle-specific biological process challenge devices that provide appropriate independent validation of each sterilization cycle of the sterilizer

This new tabletop unit addresses troublesome challenges that can affect productivity, sterility assurance and drying efficacy when using this type of sterilization process.

“We are very excited to be offering healthcare providers several valuable innovations for their low-temperature sterilization needs,” said Chief Operating Officer Stephen Loes. “The HC 80TT sterilizer is capable of delivering real improvements in productivity and cost reduction, and offers functions and accessories designed to improve users’ confidence in the sterilization process. Moreover, early testing indicates that our dynamic sterilant delivery system helps prolong the useful life of moisture and heat-sensitive reusable devices.”

The Sterilucent HC 80TT sterilizer offers additional features/technologies that help reprocessing departments save cost and improve throughput, including:

  • A large capacity 83-liter chamber that accommodates a maximum load of 14.5 kg (31.9 lbs.) and allows more instruments to be processed per cycle.
  • The capability to reprocess two flexible scopes in a single Flexible Cycle.

Hospital sterile processing departments, outpatient centers and endoscopy suites will gain additional benefits from the HC 80TT sterilizer’s user-centric design. For example, the system is easy to load and has an intuitive touch-panel interface. An optional user tracking feature is available, facilitated by easy barcode data entry. All in all, the HC 80TT VHP sterilizer brings a new level of process assurance, reprocessing productivity and user convenience to low-temperature reprocessing.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X